What Happened?
Cambridge, MA-based KSQ-Therapeutics Appointed David Meeker as Chief Executive Officer
About the Company
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed. The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates. KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts.
About the Person
David Meeker is Chief Executive Officer at KSQ Therapeutics. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile